Selecting first-line treatment for patients with chronic lymphocytic leukemia (CLL) in 2020

On February 6th and 7th we will broadcast the plenary sessions live from the Debate. Our expert faculties will discuss the importance of recent data including data presented during the American Society of Hematology (ASH) 2019 congress relating to the management of patients with acute myeloid leukemia, chronic lymphocytic leukemia, B-cell lymphomas and multiple myeloma. A focus will be on how these new data could impact current clinical practice.

Learning objective:

After participating in this session delegates should be able to:

• Explain the process for selecting first-line treatment for patients with CLL

Faculty:

• Peter Hillmen (UK)
• Steven Coutré (USA)
• Paolo Ghia (Italy)
• Carol Moreno (Spain)
• George Follows (UK)